@article{66e7197f01764a099a47f6d2f96d1108,
title = "A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis",
abstract = "Betamethasone valerate (BMV) is a medium-potency corticosteroid commonly used for the treatment of chronic psoriasis. Although occlusion has been shown to enhance the efficacy of BMV treatment, no ready-to-use occlusive BMV formulation is currently approved for the market.",
keywords = "Administration, Cutaneous, Adult, Aged, Betamethasone Valerate, Chemistry, Pharmaceutical, Double-Blind Method, Female, Glucocorticoids, Humans, Male, Middle Aged, Occlusive Dressings, Prospective Studies, Psoriasis, Questionnaires, Severity of Illness Index, Treatment Outcome, Administration, Cutaneous, Adult, Aged, Betamethasone Valerate, Chemistry, Pharmaceutical, Double-Blind Method, Female, Glucocorticoids, Humans, Male, Middle Aged, Occlusive Dressings, Prospective Studies, Psoriasis, Questionnaires, Severity of Illness Index, Treatment Outcome",
author = "Ketty Peris and A Pacifico and R Daidone",
year = "2006",
doi = "10.1111/j.1468-3083.2006.01387.x",
language = "English",
volume = "20",
pages = "153--157",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "Elsevier BV:PO Box 211, 1000 AE Amsterdam Netherlands:011 31 20 4853757, 011 31 20 4853642, 011 31 20 4853641, EMAIL: nlinfo-f@elsevier.nl, INTERNET: http://www.elsevier.nl, Fax: 011 31 20 4853598",
}